share_log

Jefferies Downgrades Collegium Pharmaceutical to Hold, Raises Price Target to $37

Jefferies Downgrades Collegium Pharmaceutical to Hold, Raises Price Target to $37

傑富瑞將Collegium Pharmical的評級下調至持有,將目標股價上調至37美元
Benzinga ·  01/04 08:09

Jefferies analyst Glen Santangelo downgrades Collegium Pharmaceutical (NASDAQ:COLL) from Buy to Hold and raises the price target from $30 to $37.

傑富瑞分析師格倫·桑坦傑洛將Collegium Pharmaceutical(納斯達克股票代碼:COLL)的評級從買入下調至持有,並將目標股價從30美元上調至37美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論